Loading...
Trading.HK
Global Markets
T.HK
News Markets

Menu

Home
Asia
Hong Kong China Japan India Singapore Taiwan
Americas
US Canada Brazil Mexico
Europe & Others
UK Germany France Australia
View All Markets →
Traditional Assets
Equities Options ETFs Bonds
Alternative Assets
Cryptocurrency Forex Commodities app.nav.macro
News
Market Analysis
Correlation Matrix Risk-Return Profile Market Sentiment Momentum Signals
View All Analytics →
Screener Compare Search Market Status
/ News / Technology

News

All News
By Category
Central Banks Commodities Corporate Corporate Actions Crypto Cryptocurrency Dividends Earnings Economic Data Forex IPOs Insider Trading Legal M&A Macro Market Update Markets Ratings Regulations Technology
Coverage
Methodology
FAQ

These Were the S&P 500’s Best and Worst Stocks in October

Published 1 week ago • Oct 31, 2025 at 5:08 PM • Positive
These Were the S&P 500’s Best and Worst Stocks in October
Auto

Related Stocks

ARE.US Alexandria Real... MU.MX Micron Technolo... MUTC34.SA Micron Technolo...
Micron Technology continued its banner year in October, with shares rising 36.1% for the month. AI has driven a surge in demand for the company’s dynamic random-access memory, or DRAM, products, giving Micron license to raise prices as customers’ inventories thin out.

Continue Reading

View Comments

More News

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

20 minutes ago Negative

Should You Buy Microsoft (MSFT) For Long-Term AI Gains?

21 minutes ago Positive

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

30 minutes ago Positive

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

35 minutes ago Negative

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

40 minutes ago Negative

Trading.HK

Your comprehensive platform for global financial markets data, analytics, and insights.

Markets

  • Asia Pacific
  • Americas
  • Europe
  • Market Status

Asset Classes

  • Equities
  • Cryptocurrency
  • ETFs
  • Forex
  • Commodities

Resources

  • Market News
  • Analytics
  • Stock Screener
  • Compare Stocks
  • Methodology
  • Coverage
  • FAQ

© 2025 Trading.HK. All rights reserved.

Privacy Policy Terms of Service Contact